Ameriprise
CORZ icon

Ameriprise’s Core Scientific CORZ Stock Holding History

Ameriprise’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28M Sell
128,348
-182,354
-59% -$4.29M ﹤0.01% 2816
2026
Q1 		$4.65M Buy
310,702
+78,145
+34% +$1.33M ﹤0.01% 2480
2025
Q4 		$3.39M Buy
232,557
+194,947
+518% +$3.4M ﹤0.01% 2715
2025
Q3 		$675K Buy
37,610
+11,328
+43% +$166K ﹤0.01% 3522
2025
Q2 		$449K Sell
26,282
-162,652
-86% -$1.63M ﹤0.01% 3567
2025
Q1 		$1.37M Sell
188,934
-21,035
-10% -$239K ﹤0.01% 3081
2024
Q4 		$2.95M Buy
+209,969
New +$3.1M ﹤0.01% 2704

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Ameriprise's CORZ Position: Q2 2026 in Review

Ameriprise reduced its Core Scientific (CORZ) stake by 59% in Q2 2026, selling an estimated $4.29M and leaving 128,348 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2816.

Ameriprise first reported a position in CORZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.65M in Q1 2026. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Ameriprise held 128,348 shares of Core Scientific worth $3.28M as of Q2 2026.
  • Ameriprise sold 182,354 Core Scientific shares in Q2 2026, an estimated $4.29M.
  • Core Scientific made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2816 holding.
  • Ameriprise first reported a position in Core Scientific in Q4 2024 and has held it in 7 quarters since.
  • Ameriprise's Core Scientific position peaked at $4.65M in Q1 2026.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.